Studies have shown that the activation of SRC proto-oncogene non-receptor tyrosine kinase (SRC) can inhibit cancer cell ferroptosis by inhibiting the expression of acyl-CoA synthetase long-chain family member 4 (ACSL4) (Brown et al., 2017; Ye et al., 2021). The gene discussed is ACSL4; the disease is cancer.